Lynch & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22M Sell
86,700
-55
-0.1% -$12.8K 3.85% 4
2026
Q1
$21.2M Sell
86,755
-1,142
-1% -$266K 3.98% 5
2025
Q4
$18.2M Sell
87,897
-1,222
-1% -$242K 3.44% 5
2025
Q3
$16.5M Sell
89,119
-999
-1% -$171K 3.19% 6
2025
Q2
$13.8M Buy
90,118
+711
+0.8% +$109K 2.77% 8
2025
Q1
$14.8M Sell
89,407
-8
-0% -$1.25K 3.21% 7
2024
Q4
$12.9M Sell
89,415
-1,385
-2% -$215K 2.81% 9
2024
Q3
$14.7M Sell
90,800
-651
-0.7% -$104K 3.11% 6
2024
Q2
$13.4M Buy
91,451
+2,293
+3% +$341K 3.01% 7
2024
Q1
$14.1M Sell
89,158
-3,604
-4% -$574K 3.26% 5
2023
Q4
$14.5M Sell
92,762
-1,107
-1% -$170K 3.53% 4
2023
Q3
$14.6M Sell
93,869
-530
-0.6% -$87.5K 3.86% 4
2023
Q2
$15.6M Sell
94,399
-396
-0.4% -$63.9K 4% 2
2023
Q1
$14.7M Sell
94,795
-1,320
-1% -$213K 3.85% 2
2022
Q4
$17M Sell
96,115
-567
-0.6% -$97.9K 4.44% 2
2022
Q3
$15.8M Sell
96,682
-1,425
-1% -$241K 4.62% 2
2022
Q2
$17.4M Sell
98,107
-70
-0.1% -$12.5K 4.74% 2
2022
Q1
$17.4M Buy
98,177
+545
+0.6% +$92.7K 4.21% 2
2021
Q4
$16.7M Buy
97,632
+1,640
+2% +$268K 3.94% 3
2021
Q3
$15.5M Sell
95,992
-13
-0% -$2.22K 4.02% 2
2021
Q2
$15.8M Sell
96,005
-727
-0.8% -$120K 4.06% 2
2021
Q1
$15.9M Buy
96,732
+1,207
+1% +$195K 4.29% 2
2020
Q4
$15M Buy
95,525
+1,338
+1% +$197K 4.09% 3
2020
Q3
$14M Sell
94,187
-1,204
-1% -$178K 4.2% 3
2020
Q2
$13.4M Sell
95,391
-2,378
-2% -$347K 4.34% 3
2020
Q1
$12.8M Sell
97,769
-460
-0.5% -$65.3K 4.71% 3
2019
Q4
$14.3M Buy
98,229
+205
+0.2% +$27.8K 4.12% 3
2019
Q3
$12.7M Sell
98,024
-305
-0.3% -$40.2K 3.88% 4
2019
Q2
$13.7M Sell
98,329
-490
-0.5% -$67.8K 4.45% 2
2019
Q1
$13.8M Buy
98,819
+1,674
+2% +$224K 4.58% 2
2018
Q4
$12.5M Buy
97,145
+1,648
+2% +$230K 4.68% 2
2018
Q3
$13.2M Buy
95,497
+3,641
+4% +$484K 4.45% 2
2018
Q2
$11.1M Sell
91,856
-212
-0.2% -$26.4K 4.04% 2
2018
Q1
$11.8M Sell
92,068
-2,210
-2% -$299K 4.51% 2
2017
Q4
$13.2M Buy
94,278
+312
+0.3% +$43.5K 4.94% 1
2017
Q3
$12.2M Buy
93,966
+256
+0.3% +$33.9K 4.85% 1
2017
Q2
$12.4M Buy
93,710
+841
+0.9% +$107K 4.9% 2
2017
Q1
$11.6M Buy
92,869
+826
+0.9% +$98.7K 4.72% 2
2016
Q4
$10.6M Buy
92,043
+1,321
+1% +$153K 4.46% 2
2016
Q3
$10.7M Sell
90,722
-1,994
-2% -$242K 4.71% 2
2016
Q2
$11.2M Sell
92,716
-604
-0.6% -$68.6K 5.02% 2
2016
Q1
$10.1M Buy
93,320
+4,118
+5% +$426K 4.8% 2
2015
Q4
$9.16M Buy
89,202
+2,801
+3% +$282K 4.7% 2
2015
Q3
$8.06M Buy
86,401
+597
+0.7% +$57.8K 4.47% 2
2015
Q2
$8.36M Buy
85,804
+2,475
+3% +$248K 4.37% 2
2015
Q1
$8.38M Buy
83,329
+355
+0.4% +$36.1K 4.41% 2
2014
Q4
$8.68M Sell
82,974
-548
-0.7% -$57.8K 4.67% 2
2014
Q3
$8.9M Buy
83,522
+925
+1% +$95.9K 5% 2
2014
Q2
$8.64M Buy
82,597
+304
+0.4% +$30.7K 4.93% 3
2014
Q1
$8.08M Buy
82,293
+580
+0.7% +$53.8K 4.77% 3
2013
Q4
$7.48M Sell
81,713
-299
-0.4% -$27.6K 4.47% 3
2013
Q3
$7.11M Buy
82,012
+1,357
+2% +$122K 4.74% 3
2013
Q2
$6.92M Buy
+80,655
New +$6.84M 4.79% 3

Other funds holding JNJ

Lynch & Associates's JNJ Position: Q2 2026 in Review

Lynch & Associates reduced its Johnson & Johnson (JNJ) stake by 0.06% in Q2 2026, selling an estimated $12.8K and leaving 86,700 shares worth $22M. The position accounts for 3.85% of the portfolio, ranked #4.

Lynch & Associates first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Lynch & Associates held 86,700 shares of Johnson & Johnson worth $22M as of Q2 2026.
  • Lynch & Associates sold 55 Johnson & Johnson shares in Q2 2026, an estimated $12.8K.
  • Johnson & Johnson made up 3.85% of Lynch & Associates's portfolio in Q2 2026, its #4 holding.
  • Lynch & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Lynch & Associates's 13F filing for Q2 2026, filed 13 Jul 2026.